Statement Of Financial Position [Abstract]

Innate Pharma - Filing #2821023

Concept	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-12-31	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2019-01-01	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31	As at 2018-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment	—	—	—	—	—	11 694 EUR	—	—	11 672 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	—	—	—	—	—	46 289 EUR	—	—	96 968 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Trade and other non-current receivables	—	—	—	—	—	29 821 EUR	—	—	16 737 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax assets	—	—	—	—	—	7 087 EUR	—	—	1 286 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Other non-current non-financial assets	—	—	—	—	—	147,000 EUR	—	—	89,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Non-current assets	—	—	—	—	—	133 972 EUR	—	—	163 756 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Current assets [abstract]
Trade and other current receivables	—	—	—	—	—	21 814 EUR	—	—	18 740 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	—	—	—	—	—	136 792 EUR	—	—	202 887 EUR	—	—	—	—	—	—	—	—	—	—	—	152 314 EUR	—	—	—	—	—
Current assets	—	—	—	—	—	173 451 EUR	—	—	237 605 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Assets	—	—	—	—	—	307 423 EUR	—	—	401 361 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	—	—	—	—	—	3 950 EUR	—	—	3 941 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Share premium	—	—	—	—	—	372 131 EUR	—	—	369 617 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Other reserves	—	—	—	—	—	355,000 EUR	—	—	472,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity	156 476 EUR	63 984 EUR	3 950 EUR	372 131 EUR	355,000 EUR	155 976 EUR	20 759 EUR	369 617 EUR	217 416 EUR	134 912 EUR	3 941 EUR	472,000 EUR	3 197 EUR	299 932 EUR	137 961 EUR	167 119 EUR	3 049 EUR	1 099 EUR	121,000 EUR	299 932 EUR	167 240 EUR	1 099 EUR	3 049 EUR	3 197 EUR	137 840 EUR	121,000 EUR
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current provisions [abstract]
Non-current provisions for employee benefits	—	—	—	—	—	4 177 EUR	—	—	3 760 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Non-current provisions	—	—	—	—	—	221,000 EUR	—	—	142,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Deferred tax liabilities	—	—	—	—	—	7 087 EUR	—	—	1 286 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Non-current liabilities	—	—	—	—	—	105 959 EUR	—	—	62 123 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Current liabilities [abstract]
Current provisions [abstract]
Current provisions	—	—	—	—	—	676,000 EUR	—	—	114,000 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Trade and other current payables	—	—	—	—	—	29 539 EUR	—	—	49 504 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Current liabilities	—	—	—	—	—	45 488 EUR	—	—	121 822 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities	—	—	—	—	—	307 423 EUR	—	—	401 361 EUR	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—